FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2163577777> ?p ?o ?g. }

• W2163577777 endingPage "254" @default.
• W2163577777 startingPage "247" @default.
• W2163577777 abstract "To determine the efficacy of tenofovir disoproxil fumarate (TDF) in adults with chronic hepatitis B virus (HBV) infection who had previously failed lamivudine (LAM) and had significant viral replication (HBV DNA >10⁵ copies/ml if HBeAg positive, > 10⁴ copies/ml if HBeAg negative) despite at least 24 weeks of treatment with adefovir dipivoxil (ADV).A prospective open-label study of TDF 300 mg daily. Patients receiving combination ADV/LAM prior to baseline were switched to TDF/LAM.Multiple tertiary referral centres.Sixty patients were enrolled. The median age was 48.5 years (range 21e80), 46 (77%) were male and 40 (67%) were HBeAg positive. Thirty-eight patients (63%) were switched from ADV to TDF, the remainder from ADV/LAM to TDF/LAM. At baseline, substitutions conferring resistance to LAM or ADV were present in 20 patients (33%) and 17 patients (28%), respectively. The median baseline viral load was 5.33 log₁₀ IU/ml (range 2.81-8.04). Patients initially treated with TDF monotherapy with persistent viral replication at or after 24 weeks were switched to TDF/LAM. The main outcome measures were change in HBV viral load from baseline and percentage of patients achieving an undetectable viral load (<15 IU/ml).Results are reported at 96 weeks of treatment. One patient discontinued TDF at 10 days due to rash. The time-weighted change in viral load from baseline to week 12 was -2.19 log10 IU/ml overall. The median change in HBV DNA from baseline to weeks 12, 24, 48 and 96 was -2.86, -3.23, -3.75 and -4.03 log₁₀ IU/ml, respectively. At 48 and 96 weeks, 27/59 (46%) and 38/59 (64%) patients achieved a HBV DNA <15 IU/ml. The response was independent of baseline LAM therapy or mutations conferring ADV resistance.In heavily pretreated patients with a high rate of genotypic resistance, TDF retains significant activity against HBV although this appears diminished in comparison with studies of naïve patients." @default.
• W2163577777 created "2016-06-24" @default.
• W2163577777 creator A5011865871 @default.
• W2163577777 creator A5013962010 @default.
• W2163577777 creator A5032626983 @default.
• W2163577777 creator A5054323549 @default.
• W2163577777 creator A5055691979 @default.
• W2163577777 creator A5063888435 @default.
• W2163577777 creator A5066288177 @default.
• W2163577777 creator A5076393700 @default.
• W2163577777 creator A5085357579 @default.
• W2163577777 creator A5085621586 @default.
• W2163577777 creator A5085854130 @default.
• W2163577777 date "2010-10-29" @default.
• W2163577777 modified "2023-10-15" @default.
• W2163577777 title "Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B" @default.
• W2163577777 cites W112572118 @default.
• W2163577777 cites W1971232580 @default.
• W2163577777 cites W1973933851 @default.
• W2163577777 cites W1976104517 @default.
• W2163577777 cites W1978314081 @default.
• W2163577777 cites W2015550128 @default.
• W2163577777 cites W2022627036 @default.
• W2163577777 cites W2046190943 @default.
• W2163577777 cites W2058376942 @default.
• W2163577777 cites W2058440632 @default.
• W2163577777 cites W2059560167 @default.
• W2163577777 cites W2062462673 @default.
• W2163577777 cites W2087416757 @default.
• W2163577777 cites W2103457558 @default.
• W2163577777 cites W2120667564 @default.
• W2163577777 cites W2147133758 @default.
• W2163577777 cites W2163782322 @default.
• W2163577777 cites W2531519772 @default.
• W2163577777 cites W2146003334 @default.
• W2163577777 doi "https://doi.org/10.1136/gut.2010.223206" @default.
• W2163577777 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21036792" @default.
• W2163577777 hasPublicationYear "2010" @default.
• W2163577777 type Work @default.
• W2163577777 sameAs 2163577777 @default.
• W2163577777 citedByCount "166" @default.
• W2163577777 countsByYear W21635777772012 @default.
• W2163577777 countsByYear W21635777772013 @default.
• W2163577777 countsByYear W21635777772014 @default.
• W2163577777 countsByYear W21635777772015 @default.
• W2163577777 countsByYear W21635777772016 @default.
• W2163577777 countsByYear W21635777772017 @default.
• W2163577777 countsByYear W21635777772018 @default.
• W2163577777 countsByYear W21635777772019 @default.
• W2163577777 countsByYear W21635777772020 @default.
• W2163577777 countsByYear W21635777772021 @default.
• W2163577777 countsByYear W21635777772022 @default.
• W2163577777 countsByYear W21635777772023 @default.
• W2163577777 crossrefType "journal-article" @default.
• W2163577777 hasAuthorship W2163577777A5011865871 @default.
• W2163577777 hasAuthorship W2163577777A5013962010 @default.
• W2163577777 hasAuthorship W2163577777A5032626983 @default.
• W2163577777 hasAuthorship W2163577777A5054323549 @default.
• W2163577777 hasAuthorship W2163577777A5055691979 @default.
• W2163577777 hasAuthorship W2163577777A5063888435 @default.
• W2163577777 hasAuthorship W2163577777A5066288177 @default.
• W2163577777 hasAuthorship W2163577777A5076393700 @default.
• W2163577777 hasAuthorship W2163577777A5085357579 @default.
• W2163577777 hasAuthorship W2163577777A5085621586 @default.
• W2163577777 hasAuthorship W2163577777A5085854130 @default.
• W2163577777 hasConcept C126322002 @default.
• W2163577777 hasConcept C142462285 @default.
• W2163577777 hasConcept C159047783 @default.
• W2163577777 hasConcept C2522874641 @default.
• W2163577777 hasConcept C2775940106 @default.
• W2163577777 hasConcept C2777382497 @default.
• W2163577777 hasConcept C2777410769 @default.
• W2163577777 hasConcept C2777869810 @default.
• W2163577777 hasConcept C2779517838 @default.
• W2163577777 hasConcept C2780593183 @default.
• W2163577777 hasConcept C2781413609 @default.
• W2163577777 hasConcept C71924100 @default.
• W2163577777 hasConcept C90924648 @default.
• W2163577777 hasConceptScore W2163577777C126322002 @default.
• W2163577777 hasConceptScore W2163577777C142462285 @default.
• W2163577777 hasConceptScore W2163577777C159047783 @default.
• W2163577777 hasConceptScore W2163577777C2522874641 @default.
• W2163577777 hasConceptScore W2163577777C2775940106 @default.
• W2163577777 hasConceptScore W2163577777C2777382497 @default.
• W2163577777 hasConceptScore W2163577777C2777410769 @default.
• W2163577777 hasConceptScore W2163577777C2777869810 @default.
• W2163577777 hasConceptScore W2163577777C2779517838 @default.
• W2163577777 hasConceptScore W2163577777C2780593183 @default.
• W2163577777 hasConceptScore W2163577777C2781413609 @default.
• W2163577777 hasConceptScore W2163577777C71924100 @default.
• W2163577777 hasConceptScore W2163577777C90924648 @default.
• W2163577777 hasIssue "2" @default.
• W2163577777 hasLocation W21635777771 @default.
• W2163577777 hasLocation W21635777772 @default.
• W2163577777 hasOpenAccess W2163577777 @default.
• W2163577777 hasPrimaryLocation W21635777771 @default.
• W2163577777 hasRelatedWork W1983206060 @default.
• W2163577777 hasRelatedWork W2076187113 @default.

• next